Portal de Murcia

www.portaldemurcia.com

The UCAM presents at the Royal Academy of Medicine its advances in drug discovery through computer (26/05/2016)

The research group `Bioinformatics and High Performance Computing (BIO-HPC) 'UCAM is the only in the region of Murcia applying structural bioinformatics for drug discovery, developing projects related diseases such as Parkinson's disease, Fabry or other inflammatory pathologies.

Also, through the initiative of Industrial Doctorates driven institution, working with the company design and synthesis of organic compounds Villapharma in the development of new drugs that could inhibit fascinates protein involved in the development of metastasis.

Researchers at BIO-HPC, one of the research groups with greater scientific productivity of the UCAM, present their activity in the 4th Session Cycle `Young researchers Murcia' Region, organized by the Royal Academy of Medicine and surgery Murcia, which will be held this afternoon at 19: 30h.

in the hall of the academy.

The Catholic University of Murcia, in its commitment to sign for the development of quality research to serve as an engine for innovation and internationalization of the business, enhances the development of leading research groups with high scientific and capable productivities implement projects meet the business needs.

BIO-HPC has been awarded TETRACOM the European call for the creation of a spin-off that offers computational chemistry to Pharma and Biotech companies, contributing to the development of new drugs.

In this European project, granted exclusively in the region of Murcia to these researchers Catholic, worked in collaboration with universities from different countries such as Italy, Hong Kong and Iceland.

Source: UCAM

This website uses cookies to facilitate and improve navigation. If you continue browsing, we consider that you accept its use. More information